Income Tax
Alnylam Pharmaceuticals Income Tax increased by 229.3% to $15.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $15.88M to $15.66M. Over 2 years (FY 2022 to FY 2024), Income Tax shows a downward trend with a 388.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase relative to pre-tax income may signal a higher effective tax rate or changes in tax legislation, while a decrease may indicate tax benefits or lower jurisdictional rates.
Detailed definition
Represents the total provision for income taxes recognized by the company during the reporting period, including both cu...
Peer comparison
Highly dependent on the company's geographic footprint and tax planning strategies compared to peers.
income_tax_expenseHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.23M | $278.00K | $985.00K | $2.73M | -$23.00K | $472.00K | $1.74M | $1.82M | $2.99M | $183.00K | $2.35M | $5.72M | $2.91M | -$110.20M | $15.88M | $30.92M | -$12.12M | $15.66M |
| QoQ Change | — | -77.4% | +254.3% | +177.1% | -100.8% | >999% | +268.4% | +4.4% | +64.6% | -93.9% | >999% | +143.7% | -49.2% | <-999% | +114.4% | +94.7% | -139.2% | +229.3% |
| YoY Change | — | — | — | +122.2% | -108.3% | — | +76.5% | -33.5% | >999% | -61.2% | +35.0% | +215.3% | -2.7% | <-999% | +576.4% | +440.4% | -516.8% | -1.4% |
Income Tax at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's income tax?
- Alnylam Pharmaceuticals (ALNY) reported income tax of $15.66M in Q1 2026.
- How has Alnylam Pharmaceuticals's income tax changed year-over-year?
- Alnylam Pharmaceuticals's income tax decreased by 1.4% year-over-year, from $15.88M to $15.66M.
- What is the long-term trend for Alnylam Pharmaceuticals's income tax?
- Over 2 years (2022 to 2024), Alnylam Pharmaceuticals's income tax has grown at a 388.2% compound annual growth rate (CAGR), from $4.16M to -$99.22M.
- What does income tax mean?
- The total amount of income tax the company is required to pay on its earnings.